Pharmaceutical maker AbbVie Inc.’s Allergan unit has agreed to pay as much as $200 million to New York state and two New York counties to settle claims that it helped create a public nuisance by permitting opioids to flood the area, in line with the corporate and the workplace of state Legal professional Basic Letitia James.
The deal removes Allergan from a lawsuit whose trial is nearing the end line. Closing arguments acquired underway Wednesday afternoon within the long-running case, which now contains Anda Inc. and different subsidiaries of father or mother firm Teva Pharmaceutical Industries Ltd. as defendants, following roughly $1.5 billion in settlements that launched half a dozen different corporations.